CTHRC1 and hepatocellular carcinoma: CTHRC1 expression is increased in hepatocellular carcinoma (46, 47), melanoma (48) and breast cancer (49) and in several studies increased mRNA and protein expression in tumors was associated with poor disease prognosis and survival (46, 49–52).